Immuneering Corporation

8-K Director or officer change Jun 15, 2026 8-K Shareholder vote results Jun 11, 2026 8-K Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 6, 2026 8-K Results of operations (earnings release) Mar 6, 2026 8-K Other events Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Entered a material agreement; Other events Sep 25, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 24, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Other events Jun 17, 2025 8-K Shareholder vote results Jun 16, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release) May 5, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Other events Jan 13, 2025 8-K Other events Jan 7, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K/A Director or officer change Oct 2, 2024 8-K Other events Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results Jun 13, 2024 8-K Director or officer change May 23, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change; Other events Mar 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 1, 2024 8-K Results of operations (earnings release) Mar 1, 2024 8-K Amended charter or bylaws Feb 2, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023